| Big Pharma's Emerging Market Fever: Abbott Aims for the Top of India's Industry The Burrill Report submits: By Marie Daghlian Emerging market M&A headlined the third week of May as Big Pharma continued its push into emerging markets. Abbott Laboratories (ABT) wasted no time after creating its Established Product Division to expand its branded generics market share, especially in emerging markets. The company announced a definitive agreement with Piramal Healthcare Limited to acquire full ownership of Piramal's Healthcare Solutions business, one of India’s top branded generics companies, for an upfront payment of $2.1 billion, plus $400 million annually for the next four years. The $3.7 billion deal will make Abbott in the leader in the Indian pharmaceutical market. Complete Story » seekingalpha.com |
NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010 (PR Newswire) NeoGenomics, Inc. announced today that it plans to release its second quarter 2010 financial results on Thursday, July 29, 2010. us.rd.yahoo.com |
Array BioPharma Inc. F4Q10 (Qtr End 06/30/10) Earnings Call Transcript Array BioPharma Inc. (ARRY)F4Q10 (Qtr End 06/30/10) Earnings Call TranscriptAugust 10, 2010 9:00 am ETComplete Story » seekingalpha.com |
Sanofi Goes Hostile on Genzyme Derek Lowe submits: As of Monday morning. It looks like they were getting nowhere with Genzyme's (GENZ) board, so they're taking their same $69/share offer directly to the shareholders. I'm not sure if that's going to be enough for them, but I presume that Sanofi-Aventis (SNY) has already sounded out some of the institutional investors before going ahead. This isn't one of those questions you ask unless you're reasonably sure of the answer. But hostile bids do fail (or get their terms sweetened along the way). We've got until midnight, December 10, which is a long enough window for a lot of things to happen. Plenty of time to get some popcorn and find a good seat.. Complete Story » seekingalpha.com |
PAREXEL International to Present at Oppenheimer Healthcare Conference and Morningstar Annual Stocks Forum [PR Newswire] - PAREXEL International Corporation announced today it will be presenting at the Oppenheimer Healthcare Conference in New York. Â James Winschel, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL at 2:45 p.m. E.T. on Wednesday, November 3, 2010. us.rd.yahoo.com |